罗苏伐他汀可减少血栓形成

摘要：

@@ A large trial of the cholesterol lowering drug rosuvastatin showed that giving1 it to healthy adults reduced their risk of blood clots (venous thromboembolism) by 43 per cent. This was the result of a subgroup analysis in the JUPITER trial2, and was published online on 28 March in The Lancet and presented at the American College of Cardiology”s 58th Annual Scientific Sessions.

机标关键词：他汀、analysis、American、College

所属期刊栏目：44

分类号：H31;V1

在线出版日期：2009-12-08（万方平台首次上网日期，不代表论文的发表时间）

页数：共2页

页码：79-80